Header Logo

Connection

Mayer Davidson to Adult

This is a "connection" page, showing publications Mayer Davidson has written about Adult.
Connection Strength

2.287
  1. In adults with BMI =27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2023 11; 176(11):JC129.
    View in: PubMed
    Score: 0.159
  2. In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2022 10; 175(10):JC116.
    View in: PubMed
    Score: 0.147
  3. Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes Care. 2022 04 01; 45(4):e84.
    View in: PubMed
    Score: 0.142
  4. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922. Diabetes Care. 2021 05; 44(5):e105.
    View in: PubMed
    Score: 0.134
  5. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
    View in: PubMed
    Score: 0.128
  6. Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
    View in: PubMed
    Score: 0.120
  7. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.116
  8. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
    View in: PubMed
    Score: 0.083
  9. Effect of long term vitamin D supplementation on biomarkers of inflammation in Latino and African-American subjects with pre-diabetes and hypovitaminosis D. Horm Metab Res. 2015 Apr; 47(4):280-3.
    View in: PubMed
    Score: 0.083
  10. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
    View in: PubMed
    Score: 0.082
  11. The reality of type 2 diabetes prevention. Diabetes Care. 2014 Apr; 37(4):943-9.
    View in: PubMed
    Score: 0.082
  12. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
    View in: PubMed
    Score: 0.080
  13. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
    View in: PubMed
    Score: 0.068
  14. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.067
  15. Integrating nurse-directed diabetes management into a primary care setting. Am J Manag Care. 2010 Sep; 16(9):652-6.
    View in: PubMed
    Score: 0.064
  16. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010 Mar; 87(3):415-21.
    View in: PubMed
    Score: 0.061
  17. Metformin does not suppress thyrotropin. Endocr Pract. 2008 Mar; 14(2):252-3.
    View in: PubMed
    Score: 0.054
  18. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
    View in: PubMed
    Score: 0.049
  19. Effective diabetes care by a registered nurse following treatment algorithms in a minority population. Am J Manag Care. 2006 Apr; 12(4):226-32.
    View in: PubMed
    Score: 0.047
  20. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
    View in: PubMed
    Score: 0.042
  21. Status of research funding by the American Diabetes Association--5th and final year. Diabetes Care. 2004 May; 27(5):1235.
    View in: PubMed
    Score: 0.041
  22. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
    View in: PubMed
    Score: 0.040
  23. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
    View in: PubMed
    Score: 0.039
  24. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999 Apr 07; 281(13):1203-10.
    View in: PubMed
    Score: 0.029
  25. Diabetes research and diabetes care. Where do we stand? Diabetes Care. 1998 Dec; 21(12):2152-60.
    View in: PubMed
    Score: 0.028
  26. Comments on the position statements "Management of dyslipidemia in adults with diabetes" and "diabetic retinopathy". Diabetes Care. 1998 Aug; 21(8):1378-9.
    View in: PubMed
    Score: 0.028
  27. Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998 Jul; 21(7):1037-43.
    View in: PubMed
    Score: 0.027
  28. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. J Clin Endocrinol Metab. 1996 Jul; 81(7):2423-7.
    View in: PubMed
    Score: 0.024
  29. Caveat to recommendations in the consensus statement. Treatment of hypertension in diabetes. Diabetes Care. 1994 Apr; 17(4):345-6.
    View in: PubMed
    Score: 0.020
  30. Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993 Oct; 58(4):555-60.
    View in: PubMed
    Score: 0.020
  31. Successful treatment of markedly symptomatic patients with type II diabetes mellitus using high doses of sulfonylurea agents. West J Med. 1992 Aug; 157(2):199-200.
    View in: PubMed
    Score: 0.018
  32. Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. JPEN J Parenter Enteral Nutr. 1992 Jan-Feb; 16(1):69-74.
    View in: PubMed
    Score: 0.017
  33. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin. Diabetes Care. 1991 Nov; 14(11):1109-10.
    View in: PubMed
    Score: 0.017
  34. Inverse relationship of metabolic clearance rate of insulin to body mass index. Metabolism. 1987 Mar; 36(3):219-22.
    View in: PubMed
    Score: 0.013
  35. The role of glucosylated serum albumin in monitoring glycemic control in stable insulin-requiring diabetic out-patients. J Clin Endocrinol Metab. 1987 Feb; 64(2):269-73.
    View in: PubMed
    Score: 0.012
  36. Pathogenesis of type 2 diabetes mellitus: an interpretation of current data. Am J Med Sci. 1986 Jul; 292(1):35-9.
    View in: PubMed
    Score: 0.012
  37. Hyperthyroid Graves' disease causes insulin antagonism. J Clin Endocrinol Metab. 1985 May; 60(5):1038-41.
    View in: PubMed
    Score: 0.011
  38. Diabetes in the elderly: diagnosis and treatment. Hosp Pract (Hosp Ed). 1982 Apr; 17(4):113-20, 125, 128-9.
    View in: PubMed
    Score: 0.009
  39. Role of ketogenesis in urinary sodium excretion: elucidation by nicotinic acid administration during fasting. J Clin Endocrinol Metab. 1979 Dec; 49(6):818-23.
    View in: PubMed
    Score: 0.008
  40. Effect of carbohydrate and noncarbohydrate sources of calories on plasma 3,5,3'-triiodothyronine concentrations in man. J Clin Endocrinol Metab. 1979 Apr; 48(4):577-81.
    View in: PubMed
    Score: 0.007
  41. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Metabolism. 1976 Apr; 25(4):455-64.
    View in: PubMed
    Score: 0.006
  42. Insulin sensitivity of the large human adipocyte in vitro. Diabetes. 1975 Dec; 24(12):1086-93.
    View in: PubMed
    Score: 0.006
  43. Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities. Diabetologia. 1975 Dec; 11(6):561-8.
    View in: PubMed
    Score: 0.006
  44. Growth hormone responses to fructose in diabetes mellitus. Acta Endocrinol (Copenh). 1974 Mar; 75(3):497-502.
    View in: PubMed
    Score: 0.005
  45. Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents. J Clin Endocrinol Metab. 1973 Feb; 36(2):246-55.
    View in: PubMed
    Score: 0.005
  46. Effect of obesity on insulin sensitivity on human adipose tissue. Diabetes. 1972 Jan; 21(1):6-12.
    View in: PubMed
    Score: 0.004
  47. Metabolic and thermal responses to Piromen in man. J Clin Endocrinol Metab. 1971 Feb; 32(2):179-87.
    View in: PubMed
    Score: 0.004
  48. Effect of isocaloric substitution of chocolate cake for potato in type I diabetic patients. Diabetes Care. 1990 Aug; 13(8):888-92.
    View in: PubMed
    Score: 0.004
  49. Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med. 1989 Aug; 87(2):178-82.
    View in: PubMed
    Score: 0.004
  50. Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab. 1988 Mar; 66(3):565-9.
    View in: PubMed
    Score: 0.003
  51. Exogenous insulin therapy slows weight loss in type 2 diabetic patients. Int J Obes. 1988; 12(2):149-55.
    View in: PubMed
    Score: 0.003
  52. Effects of reserpine on biological clocks for metabolic fuels during starvation in man. Diabetes. 1968; 17:312.
    View in: PubMed
    Score: 0.003
  53. Insulin antagonism is not a primary abnormality of amyotrophic lateral sclerois but is related to disease severity. J Clin Endocrinol Metab. 1986 Jul; 63(1):41-6.
    View in: PubMed
    Score: 0.003
  54. Studies of substrate regulation in fasting. I. Evidence for central regulation of lipolysis by plasma glucose mediated by the sympathetic nervous system. Diabetes. 1967 Aug; 16(8):576-89.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.